Juniper Biosciences is a biotechnology company based in Bridgewater, New Jersey that develops innovative radiopharmaceuticals for precision medicine. Leveraging expertise in radioisotope‑linked ligands, the firm focuses on creating diagnostic and therapeutic agents to improve early cancer detection and treatment while minimizing side effects. Their pipeline spans clinically proven solutions and novel theranostics aimed at addressing unmet needs in oncology and other disease areas.